Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18587365 | SYSTEMS, METHODS, AND APPARATUS FOR ADMINISTERING DRUGS VIA IMPLANTED ACCESS PORT | February 2024 | November 2024 | Allow | 9 | 0 | 0 | Yes | No |
| 18587202 | SYSTEMS, METHODS, AND APPARATUS FOR LOCATING SUBCUTANEOUS ACCESS PORT | February 2024 | November 2024 | Allow | 8 | 0 | 0 | No | No |
| 17626605 | SUPPLY SYSTEM AND PROCESS FOR SUPPLYING A MEDICAL DEVICE WITH A FLUID, COMPRISING A WIRELESS ACTUATING UNIT | January 2022 | June 2025 | Allow | 41 | 2 | 0 | Yes | No |
| 17618715 | KIT FOR WASHING AN INTESTINAL ANASTOMOSIS IN SITU | December 2021 | June 2025 | Allow | 42 | 0 | 0 | No | No |
| 17456971 | Communication Device for Transmitting Information from a Medicament Delivery Device | November 2021 | January 2025 | Allow | 37 | 1 | 0 | No | No |
| 17609390 | DEVICE, SYSTEM AND METHOD FOR PERIOPERATIVE PAIN MANAGEMENT | November 2021 | March 2025 | Allow | 41 | 1 | 0 | No | No |
| 17513789 | Catheter Placement System with Stiffening System | October 2021 | December 2024 | Allow | 38 | 2 | 1 | No | Yes |
| 17508105 | INTRODUCER NEEDLE HAVING A BUMP AND RELATED SYSTEMS AND METHODS | October 2021 | April 2024 | Allow | 30 | 1 | 1 | Yes | No |
| 17450754 | External Driving Mechanism | October 2021 | March 2024 | Allow | 29 | 2 | 0 | Yes | No |
| 17493265 | MICROFABRICATED CATHETER DEVICES WITH HIGH AXIAL STRENGTH | October 2021 | January 2025 | Allow | 39 | 3 | 0 | No | No |
| 17492612 | DUAL CHAMBER SYRINGE WITH A RESTRICTING ELEMENT AND METHODS OF USE THEREOF | October 2021 | July 2024 | Allow | 34 | 2 | 1 | No | No |
| 17488366 | ADJUSTABLE STIFFNESS MEDICAL DEVICES | September 2021 | January 2025 | Allow | 39 | 1 | 0 | No | No |
| 17600068 | MEDICAL INSTRUMENT WITH ANGLE ADJUSTMENT DEVICE | September 2021 | January 2025 | Allow | 39 | 1 | 0 | No | No |
| 17487226 | ONE-MOTION HANDLE FOR STEERABLE CATHETER | September 2021 | May 2024 | Allow | 32 | 2 | 0 | No | No |
| 17300571 | INJECTOR | August 2021 | December 2024 | Allow | 40 | 1 | 0 | No | No |
| 17430923 | PINCH VALVE MECHANISM | August 2021 | December 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17310503 | FLUIDIC SUBSYSTEM FOR MULTI-USE DRUG-DELIVERY DEVICE | August 2021 | March 2025 | Allow | 44 | 2 | 0 | No | No |
| 17378304 | Safety Mechanism | July 2021 | October 2024 | Allow | 39 | 1 | 0 | No | No |
| 17421524 | A BUBBLE TRAP DEVICE | July 2021 | November 2024 | Allow | 40 | 1 | 0 | Yes | No |
| 17346720 | Torque device | June 2021 | January 2025 | Abandon | 43 | 1 | 1 | No | No |
| 17303621 | Catheter Guide and Method for Operating the Same | June 2021 | June 2025 | Allow | 49 | 3 | 0 | Yes | No |
| 17296278 | DEVICE AND SYSTEM FOR DELIVERING A MEDICAL FLUID AND RELATIVE DELIVERY METHOD | May 2021 | March 2025 | Allow | 46 | 2 | 0 | Yes | No |
| 17282542 | SYRINGE FOR RECONSTITUTING AND INJECTING A PHARMACEUTICAL SOLUTION | April 2021 | August 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17282638 | SYRINGE FOR INJECTING AN INJECTABLE SOLUTION CONTAINED IN A DEFORMABLE CARTRIDGE | April 2021 | August 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17279384 | DEVICE FOR REPEATED INTRADERMAL INJECTIONS WITHIN AN ORGANIC TISSUE | March 2021 | February 2025 | Abandon | 47 | 1 | 0 | No | No |
| 17274241 | HYDRAULIC SYRINGE | March 2021 | October 2024 | Abandon | 43 | 0 | 1 | No | No |
| 17192815 | EXTENSION SET AND RELATED SYSTEMS AND METHODS | March 2021 | April 2025 | Allow | 49 | 3 | 0 | No | No |
| 17271124 | Universal Disinfecting Cap | February 2021 | October 2024 | Allow | 44 | 2 | 0 | No | No |
| 17173278 | ROBOTIC SURGICAL INSTRUMENTS WITH ROTARY SHAFT POWER TRANSMISSION | February 2021 | May 2025 | Allow | 51 | 2 | 1 | No | No |
| 17172817 | FLUID DELIVERY SYSTEMS AND METHODS | February 2021 | April 2025 | Abandon | 50 | 2 | 0 | No | No |
| 17160764 | ALTERNATIVE DEVICE FOR ADJUSTING A DOSAGE WITH A LIMITING MECHANISM FOR A DEVICE FOR ADMINISTERING A PRODUCT | January 2021 | July 2024 | Allow | 42 | 1 | 0 | Yes | No |
| 17263254 | INFUSION SYSTEM HAVING AN INFUSION PUMP AND HAVING A PUMP MODULE THAT CAN BE COUPLED THERETO | January 2021 | July 2024 | Allow | 41 | 2 | 0 | No | No |
| 17263064 | MOUNTING DEVICE FOR ADAPTING A FOLEY URINARY CATHETER AS A PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (PEG) CATHETER FOR ENTERAL FEEDING | January 2021 | June 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17154777 | GUIDEWIRE HAVING ENLARGED, MICRO-FABRICATED DISTAL SECTION | January 2021 | August 2024 | Allow | 43 | 2 | 0 | No | No |
| 17259441 | PUNCTURE DEVICE FOR ACCESSING THE VASCULAR SYSTEM | January 2021 | January 2025 | Allow | 48 | 3 | 0 | Yes | No |
| 17140631 | HYDROGEN-DELIVERING SYSTEM FOR A BODILY ORIFICE | January 2021 | November 2024 | Allow | 46 | 1 | 1 | No | No |
| 17252084 | SYSTEM AND METHOD FOR INJECTING POULTRY | December 2020 | June 2025 | Allow | 54 | 3 | 0 | Yes | No |
| 17053414 | COUPLING MECHANISMS FOR MEDICAL DEVICES | November 2020 | March 2025 | Allow | 53 | 3 | 1 | No | No |
| 17050573 | PRESSURE SENSITIVE NEEDLE POSITIONING DEVICES, RELEASE MECHANISMS, AND METHODS | October 2020 | June 2024 | Abandon | 43 | 1 | 0 | No | No |
| 17031990 | CATHETER AND RECANALIZATION CATHETER SYSTEM | September 2020 | March 2024 | Allow | 42 | 1 | 0 | Yes | No |
| 17032758 | GASKET PRESSING TOOL FOR SYRINGE OR LIQUID MEDICINE EJECTION TOOL, AND LIQUID MEDICINE ADMINISTRATION TOOL INCLUDING THE SAME | September 2020 | September 2024 | Abandon | 48 | 1 | 1 | No | No |
| 17029477 | DEVICE FOR THE LOCAL APPLICATION OF AND/OR FOR FLUSHING WITH PHARMACEUTICAL FLUIDS | September 2020 | March 2025 | Allow | 54 | 2 | 0 | Yes | No |
| 17022814 | DRUG SUPPLY DEVICE | September 2020 | November 2024 | Allow | 50 | 1 | 1 | Yes | No |
| 16980256 | OPHTHALMOLOGICAL SURGICAL SET AND A CONTACT LENS | September 2020 | January 2025 | Abandon | 52 | 3 | 0 | No | No |
| 16960249 | Drug Delivery Device with Drive Sub-Assembly | July 2020 | December 2024 | Allow | 53 | 2 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner RITCHIE, HADEN MATTHEW.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 100.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner RITCHIE, HADEN MATTHEW works in Art Unit 3783 and has examined 43 patent applications in our dataset. With an allowance rate of 74.4%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 42 months.
Examiner RITCHIE, HADEN MATTHEW's allowance rate of 74.4% places them in the 31% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by RITCHIE, HADEN MATTHEW receive 1.60 office actions before reaching final disposition. This places the examiner in the 43% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by RITCHIE, HADEN MATTHEW is 42 months. This places the examiner in the 5% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +36.7% benefit to allowance rate for applications examined by RITCHIE, HADEN MATTHEW. This interview benefit is in the 87% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 43.8% of applications are subsequently allowed. This success rate is in the 95% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 69.2% of cases where such amendments are filed. This entry rate is in the 90% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 99% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 100% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.